The Anti-VEGF Antibody Bevacizumab Potently Reduces the Growth Rate of High-Risk Neuroblastoma XenograftsLova Segerström, Faranak Azarbayjani|Pediatric Research|2006Cited by 96
Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth <i>in vitro</i> and <i>in vivo</i>Lova Segerström, John Inge Johnsen|International Journal of Cancer|2011Cited by 60